UNSPSC 51282401: Amdinocillin or mecillinam

This classification denotes a penicillin antibiotic with the molecular formula C15H23N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V10579P3QZ, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2s-(2alpha,5alpha,6beta))- but generally known as amdinocillin, which bears US NIH Compound Identifier 36272. Amdinocillin most often comes in mecillinam and pivoxil forms.

UNSPSC 51282401 Amdinocillin or mecillinam is a Commodity code for a specific antibiotic pharmaceutical product, but state and local governments are purchasing this code through piggyback and cooperative purchasing arrangements rather than direct procurement of amdinocillin or mecillinam itself. The recent contract activity under this code does not reflect purchases of amdinocillin or mecillinam; instead, issuing bodies are accessing pharmaceutical warehouse supply contracts through established cooperative purchasing consortia such as MMCAP Infuse to procure broad categories of antibiotics and other medications, as well as non-pharmaceutical health and safety products like naloxone and drug deactivation systems. State and local health departments and county public health agencies are the primary issuing bodies, leveraging piggyback awards and competitive bidding processes to supply their operational and emergency response needs. The cooperative purchasing model allows jurisdictions to avoid individual solicitation cycles by drawing on pre-negotiated vendor agreements.

Activity under this code is geographically sparse and does not support a meaningful pursue strategy. The Illinois Department of Public Health executed a piggyback pharmaceutical warehouse award through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride totaling $2.99 million over the life of the contract, with an initial 12-month term and renewal options for years 2 and 3. Seminole County, Florida posted an IFB in June 2026 for Naloxone and Safe Drug Deactivation Systems with 1,900 units of naloxone and 800 deactivation systems required annually on a two-year initial term with one-year renewal option. Neither opportunity directly reflects procurement of amdinocillin or mecillinam, and the code shows no recent solicitations aligned with its nominal pharmaceutical scope. The mismatch between the code taxonomy and the actual goods being purchased suggests this code may be misclassified in state and local systems or represents a narrow product line with minimal current procurement velocity at the state and local level.